AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 4/30

$0.15−0.01 (-3.59%)

Close on Nov 13, 2026Market cap $7.63MP/E –Yield –

AEON Biopharma gross margin

Gross margin is gross profit as a percentage of revenue.

AEON Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?